• NY N344588
• Dec 23, 2024

• Type: Classification • HTSUS: 2933.59.3600
  

The tariff classification of Letermovir (CAS No. 917389-32-3) in bulk form, from India

• NY N337227
• Jan 12, 2024

• Type: Classification • HTSUS: 2933.59.3600
  

The tariff classification of Rilpivirine (CAS No. 500287-72-9) in bulk form, from Canada

• NY N334168
• Aug 15, 2023

• Type: Classification • HTSUS: 2933.59.5300
  

The tariff classification of Ensifentrine (CAS No. 1884461-72-6) in bulk powder form, from Portugal

• NY N329297
• Dec 07, 2022

• Type: Classification • HTSUS: 2933.59.5300
  

The tariff classification of Ruxolitinib Phosphate (CAS No. 1092939-17-7) in bulk powder form, from Taiwan

• NY N329037
• Nov 21, 2022

• Type: Classification • HTSUS: 2933.59.5300
  

The tariff classification of Trilaciclib Dihydrochloride (CAS No. 1977495-97-8) and Ruxolitinib Phosphate (CAS No. 1092939-17-7) in bulk form, from Taiwan

• NY N320984
• Sep 07, 2021

• Type: Classification • HTSUS: 2933.59.5300
  

The tariff classification of Vibegron (CAS No. 1190389-15-1) in bulk form, from India

• NY N318947
• May 14, 2021

• Type: Classification • HTSUS: 2933.59.5300; 3004.90.9220
  

The tariff classification of Vericiguat (CAS No. 1350653-20-1) in bulk form and Verquvo® Tablets in dosage form, from Germany

• NY N317830
• Mar 22, 2021

• Type: Classification • HTSUS: 2933.59.5300
  

The tariff classification of Sitagliptin Phosphate Monohydrate (CAS No. 654671-77-9) in bulk form, from Spain

• NY N316489
• Jan 12, 2021

• Type: Classification • HTSUS: 2934.99.3000; 2933.79.8500; 2933.59.5900
  

The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan

• NY N308708
• Jan 27, 2020

• Type: Classification • HTSUS: 2933.59.5900
  

The tariff classification of Acyclovir (CAS No. 59277-89-3) in bulk form, from Spain